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Viral replication efficiency is in large part governed by the
ability of viruses to counteract pro-apoptotic signals
induced by infection of host cells. In HHV-8, one group of
proteins acting to suppress the host’s innate defenses is
the set of four viral interferon regulatory factors (vIRFs 1-
4), which act to block cellular IRF activities in addition to
targeting and inhibiting p53 and other inducers of apopto-
sis. We observed that in a large proportion of endothelial
cells supporting lytic reactivation, the normally cytoplas-
mic pro-apoptotic BH3-only protein Bim, a negative regu-
lator of HHV-8 productive replication, was localized in the
nucleus. Nuclear localization of Bim could be induced in
cells cotransfected with vIRF-1, and confocal microscopy
identified co-localization of vIRF-1 and Bim in the nuclei
of lytically reactivated cells. Physical association of vIRF-1
and Bim was identified in co-precipitation experiments
using both transfected cell lysates and purified recombi-
nant vIRF-1 and Bim. In vitro binding studies using a ser-
ies of truncation and point variants of vIRF-1 enabled
precise mapping of the Bim-interacting residues (Bim-
binding domain, BBD) of vIRF-1. Wild-type, but not
mutated, BBD fused to a nuclear localization signal was
sufficient to induce Bim nuclear translocation in trans-
fected cells; BBD-mutated vIRF-1 proteins were unable to
do so or to protect cells from Bim-induced apoptosis.
Depletion of endogenous vIRF-1 led to reductions in virus
production and increased apoptosis in lytically reactivated
endothelial cultures, while transduced expression of wild-
type vIRF-1 promoted virus production and inhibited
apoptosis. Experimental utilization of Bim-refractory vIRF-
1 variants revealed the importance of vIRF-1:Bim interac-
tion, specifically, for pro-replication and anti-apoptotic
activity of vIRF-1. Furthermore, blocking of the interaction
with cell-permeable peptide corresponding to the Bim-
binding region of vIRF-1 confirmed the relevance of vIRF-
1:Bim association to vIRF-1 pro-replication activity. To
our knowledge, this is the fir s tr e p o r to fa nI R Fp r o t e i n
that interacts with a Bcl-2 family member and of nuclear
sequestration of Bim or any other member of the family as
a means of inactivation. Our data reveal a novel mechan-
ism utilized by a virus to control replication-induced
apoptosis and suggest that inhibitory targeting of vIRF-1:
Bim interaction may provide an effective antiviral strategy.
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